Details for Patent: 11,040,004

Which drugs does patent 11,040,004 protect, and when does it expire?

Patent 11,040,004 protects OTIPRIO and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 11,040,004

Title:	Otic gel formulations for treating otitis externa
Abstract:	Disclosed herein are methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Inventor(s):	Lebel; Carl (Malibu, CA)
Assignee:	OTONOMY, INC. (San Diego, CA)
Application Number:	15/705,101
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 11,040,004

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Alk Abello	OTIPRIO	ciprofloxacin	INJECTABLE, SUSPENSION;OTIC	207986-001	Dec 10, 2015		DISCN	Yes	No						THE TREATMENT OF ACUTE OTITIS EXTERNA IN PATIENTS 6 MONTHS OF AGE AND OLDER DUE TO PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS

International Family Members for US Patent 11,040,004

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	3512513
World Intellectual Property Organization (WIPO)	2018053173